HOMA-IR z-scores were associated with increased risks for incident lung disease, interstitial lung abnormalities, and ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

The method also works for other forms of cancer where resistance may develop. A step is now being taken towards better and more personalized treatment for the disease. Every year, around 85 Swedes ...

In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...

INR:8341. praful patel Sotatercept for improving pulmonary vascular resistance received FDA breakthrough therapy designation Antengene's ATG-010 registration clinica ...